FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis Ruby Khatun Khatun15 Dec 2017 10:06 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...
USFDA accepts application for Indivior's new schizophrenia drug Ruby Khatun Khatun15 Dec 2017 9:45 AM ISTU.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
Gilead Sciences new drug keeps 56 percent of lymphoma trial patients alive Ruby Khatun Khatun11 Dec 2017 10:30 AM ISTMore than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
Roche's Foundation Medicine wins FDA approval for new cancer test Ruby Khatun Khatun6 Dec 2017 9:30 AM ISTZURICH: Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand...
FDA moves to speed nicotine replacement product development Ruby Khatun Khatun30 Nov 2017 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) said on Wednesday it is considering measures to speed development of products that help people quit...
FDA approves first two-drug HIV regimen from GSK Ruby Khatun Khatun24 Nov 2017 10:37 AM ISTNEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
Roche sues Pfizer to bar biosimilar of cancer drug Herceptin Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTRoche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
FDA backs Roche Gazyva in first-line follicular lymphoma Ruby Khatun Khatun20 Nov 2017 9:30 AM ISTZURICH: The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma,...
FDA clears nerve stimulator for opioid withdrawal symptoms Ruby Khatun Khatun18 Nov 2017 10:00 AM ISTThe U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid...
FDA approves treatment for rare genetic enzyme disorder Ruby Khatun Khatun17 Nov 2017 10:30 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited...
